Oppenheimer sees stronger growth at Boston Scientific
Go back to Oppenheimer sees stronger growth at Boston Scientific| Abbott Laboratories (NYSE: ABT) | Delayed: 87.69 -1.96 (2.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.65 | 52 Week High | $46.38 | |||
| Open | $89.62 | 52 Week Low | $36.00 | |||
| Day High | $90.29 | P/E | 58.46 | |||
| Day Low | $87.07 | EPS | $1.50 | |||
| Volume | 2,789,695 | |||||
| Boston Scientific (NYSE: BSX) | Delayed: 46.31 -0.86 (1.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.17 | 52 Week High | $24.79 | |||
| Open | $47.60 | 52 Week Low | $15.67 | |||
| Day High | $47.80 | P/E | N/A | |||
| Day Low | $45.99 | EPS | $-0.09 | |||
| Volume | 3,766,093 | |||||
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 73.96 -1.29 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.25 | 52 Week High | $96.38 | |||
| Open | $75.57 | 52 Week Low | $47.92 | |||
| Day High | $76.25 | P/E | N/A | |||
| Day Low | $73.53 | EPS | $-0.42 | |||
| Volume | 697,211 | |||||
| Insulet Corporation (NASDAQ: PODD) | Delayed: 146.59 -2.6 (1.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.19 | 52 Week High | $45.60 | |||
| Open | $149.61 | 52 Week Low | $23.94 | |||
| Day High | $150.57 | P/E | N/A | |||
| Day Low | $145.14 | EPS | $-1.00 | |||
| Volume | 126,220 | |||||
| TANDEM DIABETES (NASDAQ: TNDM) | Delayed: 16.29 +0.49 (3.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.80 | 52 Week High | $12.48 | |||
| Open | $15.56 | 52 Week Low | $1.60 | |||
| Day High | $16.29 | P/E | N/A | |||
| Day Low | $15.51 | EPS | $-6.33 | |||
| Volume | 385,439 | |||||

